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Sheep red blood cell rosette formation has been demonstrated in a number of labora- 
tories to be a specific marker for human T  cells  (1-3). A variety of different methods 
have been utilized which have shown some differences in  the percentages of T  cells 
that form these rosettes. The procedure of Jondal and Wigzell (2)  gives values close 
to  100%  for peripheral blood T  cells  and  for thymocytes.  Recently double labeling 
experiments utilizing markers for B cells along with the rosette system have indicated 
that  independent  cells  are  involved although  rare  double  labeled  cells  may  be  ob- 
served (3).  The simplicity and specificity of the procedure have led to wide  clinical 
use of this method and valuable information has been obtained (3, 4). 
In the course of investigations on the T  cell receptor for the sheep red blood 
cells, it was noted  that neuraminidase  treatment of peripheral  blood lympho- 
cytes  considerably  enhances  their  capacity for  rosette  formation.  A  study  of 
this system indicated that a population of presumed B cells also formed rosettes 
after  such  treatment. 
Materials and Methods 
Lymphocyte Separation.--Peripheral blood ]ymphocytes  (PBL) were isolated  from  hepa- 
rinized  venous  blood of normal  adults  and  of patients  with  chronic  lymphocytic  leukemia 
(CLL),  by  Ficoll-Hs~aque  (F/H)  gradient  centrifugation  followed by passage  over  n}qon 
columns in some experiments. For sheep red blood cell rosette  (SRBC-R) formation  the cells 
were suspended  in  Hanks'  balanced  salt  solution  (HBSS) at  a  concentration  of  5  )<  106 
cells/m].  For immunoglobulin staining  and  aggregate  binding the cells were suspended at a 
concentration  of  15  20  )<  ~06 cells/ml in  2%  bovine serum  albumin  (BSA) in phosphate- 
buffered saline  (PBS) pH  7.2 containing  0.02% Na azide  (BSA-PBS). Monocytes  in  these 
preparations  were quantitated by latex bead phagocytosis. 
2~reparal@n of SRBC-R.--Rosettes  were prepared  according to the method  described pre- 
viously (3). 0.1 nfl of 0.5% SRBC in HBSS, 0.l ml lymphocyte suspension (5  X 106 cells/ml), 
and 0.02 ml of heat-inactivated  pooled human AB serum (Grand Island Biological, Co., Grand 
* This investigation  was supported  by U.S. Public Health Service Grants  No. AM 09792 
and No. AI 09338. 
Recipient of U.S. Public Health Service International  Postdoctoral  Fellowship. 
§ Recipient  of a Research Career Development Award No. 5 KO4HL-42575-04. 
1532  ¢~tE  JOURNAL  OF  EXPERIMENTAL  -~IEDICINE  •  VOLUME  137,  1973 BENTWICH  ET  AL.  BRIEF  DEFINITIVE  REPORT  1533 
Island, N. Y.) which had been previously absorbed with an equal volume of packed SRBC, 
or of HBSS, were mixed thoroughly and incubated at 37°C for 5 rain. The mixture was then 
centrifuged at 50 g for 5 rain at room temperature and incubated at 4°C  for 60 min. The cell 
pellet was resuspended by very gently rocking the tubes. A minima of 200 lymphocytes were 
counted in a hemacytometer and lymphocytes were counted as rosette positive if any SRBC 
were  adherent to them.  (Small  rosettes,  if  1-2  SRBC  adhered to  a  lymphocyte and large 
rosettes, if 3 or more SRBC adhered to one cell.) 
Separation of Rosettes from Nonrosette Lymphocytes.--1.5  ml  of  SRBC-R containing sus- 
pension was layered on 1.5 ml of the F/H  mixture, used for the lymphocyte isolation, in a 
12  X  75  mm polypropylene tube  (Falcon Plastics,  Div.  of BioQuest,  Oxnard,  Calif.),  and 
centrifuged for  20 min  at 400  g.  The nonrosetting lymphocytes remained at the interface 
between the cell suspension and the F/H  mixture.  The lymphocytes at the interface were 
pipetted off carefully and the percentage of rosettes in both this layer and the rosette-contain- 
ing bottom layer counted. 
[mmunoglobulin Reagents and  Fluorescence.--A polyvalent  antihuman  immunoglobulin 
antiserum, raised in rabbits and conjugated with tetramethyl rhodamine isothiocyanate, was 
utilized as described previously (5). The antiserum was specific for Ig and was broadly reactive 
with mu, gamma, kappa, and lambda determinants. It was routinely centrifuged to remove 
aggregates  immediately before  use.  Aggregated  human immunoglobulin was  prepared  and 
conjugated  to  tetramethyl  rhodamine isothiocyanate according  to  the  method  previously 
described (5). 
Immunofluorescence staining of lymphocyte surfaces for Ig and for aggregate binding was 
performed as described previously  (5).  In some experiments lymphocytes were first stained 
with fluorochrome conjugates and  then incubated with  SRBC  as  described for preparing 
SRBC-R.  In these experiments the SRBC-R and the fluorescence of the lymphocytes were 
studied and counted in the same preparation. 
Neuraminidase.--Two  preparations of  neuraminidase from  Vibrio cholerae (VCN)  were 
utilized in these studies. The first was obtained from Calbiochem., San Diego, Calif. The second 
preparation was  a  highly purified enzyme preparation free of aldolase,  protease,  and  leci- 
thinase C  activity, kindly provided by Dr. R. Doljansky. Various concentrations of  enzyme 
or an equivalent volume of HBSS were added to cell suspensions and incubated at 37°C  for 
30 min. After incubation, both control- and VCN-treated cells were washed in HBSS,  re- 
counted, and distributed for either fluorescence staining or rosette formation, as  previously 
described. 
Electron Microscopy.--Cell pellets were fixed  in 1.5% redistil!ed glntaraldehyde in 0.1 M 
sodium cacodylate and postfixed in  1.0%  osmium tetroxide  (6).  After brief glutaraldehyde 
fixation pellets were incubated in colloidal iron particles according to the method of Gasic 
et al.  (7). The preparations were en bloc stained with 1.0%  aqueous uranyl acetate, dehy- 
drated,  and embedded in Epon.  These sections were stained with uranyl acetate and lead 
citrate  and  examined  in  a  Siemens  101  electron microscope  (Siemens Corp.,  Medical  In- 
dustrial Div,, Iselin, N. J.). 
RESULTS 
Effect of Neuraminidase on SRBC-R Formation by Normal PBL.--Treatment 
of normal human  PBL  by neuraminidase was found to increase the percentage 
of  PBL  which  formed  SRBC  rosettes.  This effect was  dependent  on  the con- 
centration  of  the  enzyme;  reaching  its  maximum  at  25-50  U  to  107  cells/ml. 
Under  these  conditions,  up  to  94%  of  PBL  formed  rosettes  (Table  I).  The 
average  increase in percentage  of  rosette-forming  cells was  13 %.  However,  in 
one normal donor (S.F.)  known for a  relatively low number  of rosette-forming 
cells  and  high  B  cell  counts,  a  greater  increase  in  the  percentage  of  rosette- 1534  BENTWICH  ET  AL.  BRIEF  DEFINITIVE  REPORT 
forming cells, from 61% to 86%, was observed. No further increase of rosette 
formation was observed when higher enzyme concentration or longer incuba- 
tion  periods  were  used.  Both  preparations  of  neuraminidase  gave  similar 
results. 
The  enhancement  of rosette  formation  by VCN was  also  apparent  in  the 
size and strength of the rosettes formed. Most of them were composed of more 
than six  SRBC attached  to the central  lymphocyte and  at  the same time no 
small  rosettes  containing only two or three red cells  were observed as  in  the 
untreated  preparations.  In addition  the  rosettes  were  much more stable  and 
TABLE I 
l'Ject of Neuraminidase on SRBC-R Formation by Normal Human Lymphocyles 
Subject  Untreated  rosettes  NeuramJnidase-treated* rosettes 
%  % 
z.B.  80  93 
S.P.  81  94.5 
R.B.  82  94 
D.M.  73  91 
P.W.  83  92.6 
C.D.  84  93 
P.J.  79  93.5 
S.F.  61  86 
Mean  78.9  92.2 
Range  61-84  86-94.5 
* Concentration of 50 U/ml. 
less prone to disruption by manipulation. Under these conditions, the lymphoid 
cells  were  alive  as  judged  by  trypan  blue  exclusion  and  appeared  morpho- 
logically intact  and unagglutinated when viewed through a  light microscope. 
Large  cells  and  small  cells  which  picked  up  latex  particles  were  excluded 
from the  counts.  Neuraminidase-treated  SRBC whether reacted  with  normal 
or with  VCN-treated  lymphocytes did  not  affect  the  rosette  formation. 
Characterization  of  the  Lymphocytes  Affected  by  Neuraminidase.--Studies 
were  directed  toward  finding  the  explanation  for  the  increased  percent  of 
SRBC  rosettes  after  neuraminidase  treatment.  Ig  staining  and  uptake  of 
aggregated  -y-globulin  were  unaltered  and  the  same  percentage  of  PBL 
stained with the two B cell reagents before and after neuraminidase treatment. 
A  direct  assessment  of  the  populations  bearing  both  markers  was  next  per- 
formed. Normal PBL either before or after incubation with VCN, 50 U to 107 
cells/ml, was first incubated with rhodamine-conjugated anti-Ig or aggregated 
~/-globulin,  thoroughly washed, and then rosette-forming capacity determined. 
Thus,  it  was  possible  to  directly  determine  how  many labeled  cells,  i.e.  B 
cells,  also  formed  rosettes.  The  results  of  representative  experiments  are 
shown in Table II. It can be seen from these experiments that after neuramini- BENTWICH  ET  AL.  BRIEF  DE~'INITIVE  REPORT  1535 
dase treatment a significant number of presumed B cells with surface Ig formed 
rosettes. 
In order to further characterize this subpopulation the effect of neuraminidase 
on an enriched normal B cell population was studied. Such enriched populations 
were  obtained  by  separation  of  rosetting  from nonrosetting  cells  over  F/H. 
One  portion  of the  nonrosetting  cells  from the  interface  was incubated  with 
VCN after which a  determination  of their surface Ig and rerosetting capacity 
TABLE II 
Increase in the Percentage of Lymphocytes Showing Combined Ig Staining and SRBC Rosettes 
after Neuraminidase Treatment 
Rosettes  Ig staining  Rosettes:~  -b Ig 
staining 
%  %  % 
Exp. I normal PBL  80  20  0 
VCN-PBL  93  19  10 
Exp. II normal PBL  82  16  1 
VCN-PBL  93  17  11 
Enriched B cells*  14  86  2 
VCN-enriched B cells  63  80  42 
* Prepared by one step centrifugation after initial rosetting. 
~: Mixed Ig-staining rosettes were determined in separate experiments. 
was performed; another portion was analyzed separately for Ig staining within 
the rosettes. The results of a representative  experiment are shown in Table II. 
It can be seen  that  a  marked  enrichment  of B  cells  (86%)  and  a  parallel  de- 
crease in the number of rosette-forming cells  (14 %)  were obtained.  However, 
after VCN treatment  63 %  of the cells in this population formed rosettes.  No 
significant decrease in  the number of Ig-staining cells was observed,  although 
there  was some evidence of a  decrease in the intensity of the surface staining 
of some cells. The double labeling experiments on the VCN-treated enriched B 
population  revealed  a  marked  increase  in  ceils  containing both  markers  to- 
gether  (i.e.  Ig-bearing  lymphocytes-forming rosettes).  This  effect  of the  en- 
zyme on  B cells  was  apparent  whether  the  rosetting  was  performed  in  the 
presence  or absence of absorbed  AB  serum.  These  effects were  also unrelated 
to monocytes in  some  of the  preparations;  passage  over  nylon  columns  did 
not  affect  the double labeled  cells. 
Rosette Formation After VCN Treatment of CLL Lymphocytes.--The majority 
of the lymphocytes from patients with CLL do not form SRBC-R, but have B 
lymphocyte  markers.  Five  such  cases  where  the  leukemic  cells  showed  Ig 
staining,  uptake  of aggregated T-globulin and very few rosettes were studied. 
After  neuraminidase  treatment  there  was  no  significant  increase  in  rosette 
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Additional  Experiments  Including  Electron Microscopy.--A  number  of 
experiments  were  carried  out  to  study  the  alterations  on  the  lymphocyte 
surface  through  the  action  of neuraminidase.  It would  be  expected  that  the 
cell surface charge would be altered and clear evidence for such alteration was 
obtained.  Charged colloidal iron particles are known to bind to red cell mem- 
branes and can be visualized by electron microscopy (7).  This binding is lost 
after neuraminidase  treatment.  Similar findings were made on lymphocytes in 
the  present  study.  T  cells which  formed  SRBC  rosettes showed  a  coating of 
the  iron particles over their surface;  this completely disappeared after neura- 
minidase. 
Previous studies  (3)  have shown that the  SRBC  rosettes on T  cells have an 
unusual characteristic in the electron microscope. In contrast to other types of 
rosettes  the  red  cells  in  this  situation  show  point  attachment  or  in  narrow 
zones  to  the  lymphocyte  surface.  After  neuraminidase  treatment  a  striking 
change was observed and broad zones of attachment and intimate association 
of  the  red  cell  and  lymphocyte  plasma  membranes  were  observed.  These 
observations will  be published  in  detail  elsewhere. 
DISCUSSION 
The present  observations suggest  that  after neuraminidase  treatment  of T 
cells additional sites are exposed on the lymphocyte surface resulting in broad 
zones of attachment of the SRBC and an increase in the number of cells bound 
to each lymphocyte. Such a process would also explain the more stable rosettes 
that  were  observed. 
The finding that the enzyme effect also caused a  population of presumed B 
cells to acquire the  SRBC rosette-forming property was unexpected. This was 
clearly  evident  from  double  labeling  experiments  where  lymphocytes which 
showed Ig on their surface with fluorescent antisera also formed rosettes. These 
same cells also had the Fc receptor as determined by the uptake of aggregated 
T-globulin, another specific characteristic of B  cells.  The experiments indicated 
that  approximately half of the presumed B  ceils acquired  the  rosette-forming 
property;  the  other half showed  no such  effect irrespective of the  amount of 
neuraminidase  and duration  of treatment.  It would  appear that  the  leukemic 
lymphocytes in  the  five cases  of  CLL  studied  related  to  this  neuraminidase 
resistant population since they too failed to form rosettes.  The interpretation 
of these findings is not entirely clear.  The most likely explanation  is perhaps 
that  there  are  two  distinct  B  cell  populations  that  can  be  identified  by the 
neuraminidase  effect.  Alternatively  it  might  be  that  the  affected Ig-bearing 
cells form a  subpopulation  of T  cells  that  have  an  Fc  receptor and  perhaps 
adsorb Ig from the  serum.  Some evidence for such T  cells has been obtained 
in the mouse (8). It is known that  the percentage of peripheral blood lympho- 
cytes  that  have  the  complement receptor is  consistently lower  than  the  per- 
centage bearing Ig (5). This difference has been ascribed to the very different 
techniques  utilized  but  perhaps  this  relates  to  the  present  findings.  Experi- BENTWICH ET  AL.  BRIEF  DEFINITIVE REPORT  1537 
ments  are  underway  to  elucidate  this  question.  The  fact  that  neuraminidase 
treatment  had marked  effects on the  rosette  system is not surprising  in  view 
of previous  observations  on the  increased  absorptive  capacity and  sensitivity 
of lymphocytes to a  variety of antibodies  (9,  10). 
SUMMARY 
Neuraminidase  treatment  of  normal  human  lymphocytes  enhances  their 
capacity  to  form  SRBC  rosettes;  more  red  cells  are  bound  and  the  rosettes 
are  more  stable.  Under  these  conditions  approximately  90 %  of  peripheral 
blood lymphocytes form rosettes.  In addition  to the effects on T  cells, another 
population  of  lymphocytes  which  possess  surface  immunoglobulin  and  have 
the Fc receptor acquire the rosette-forming property after neuraminidase.  This 
subpopulation of 'B' cells represents approximately half of the lymphocytes with 
surface immunoglobulin but is not found among the leukemic lymphocytes of 
patients with chronic lymphocytic leukemia.  Electron microscope observations 
indicate  close  approximation  and  intimate  association  of  the  red  cell  and 
lymphocyte membranes  after neuraminidase. 
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